Viewing nowCombinationAnoforized 5/80 milligrams
Valsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Samsung Pharma Co., Ltd.

MFDS item code 201308505 · Approved 2013.07.30
Treatment of essential hypertension not adequately controlled with monotherapy
For patients with essential hypertension, when blood pressure is not adequately controlled with either amlodipine or valsartan monotherapy, this medicine helps to lower blood pressure more effectively by using both drugs together. Such combination therapy helps manage blood pressure stably, thereby reducing the risk of cardiovascular complications and contributing to maintaining a healthy life. This medication improves hypertension control and contributes to enhancing the quality of life for patients.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). This medicine must not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This drug can cause serious harm to the fetus during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This drug should not be taken by individuals who are allergic to the active ingredient, pregnant or nursing women, and patients with severe kidney or liver problems. Patients with a deficiency of sodium or body fluids may experience hypotension, so their condition should be carefully checked before using this drug, and blood pressure and condition should be closely monitored during treatment. Patients with elevated potassium levels or those taking medications that may increase potassium levels should have their potassium levels checked regularly. Patients with renal vascular problems or those who have recently undergone a kidney transplant should use this drug cautiously due to the risk of deteriorating kidney function. Should any symptoms of angioedema (swelling of the face, lips, tongue, etc.) occur while taking this medication, it should be discontinued immediately and medical advice sought. Patients with heart failure or after a myocardial infarction should periodically monitor changes in kidney function and blood pressure while on this drug and be cautious of side effects such as pulmonary edema. Patients with acute myocardial infarction or certain heart diseases such as aortic stenosis also require special caution when using this drug. This drug may interact with other antihypertensive agents, potassium-sparing diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), so it is important to inform healthcare providers of all medications being taken. Caution should be exercised when driving or operating machinery as dizziness or fatigue may occur. In case of overdose, hypotension, dizziness, and in severe cases, shock may occur, so an immediate visit to a healthcare facility is necessary. The safety and efficacy of this drug has not been established for patients under 18 years of age, hence it is not recommended for children. For the elderly, the same dosage can be administered as for adult patients. Pregnant or nursing women should avoid taking this medicine and should discontinue immediately upon confirmation of pregnancy.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, sweating, rash, itching, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, bowel vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, dysgeusia, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuropathy, Stevens-Johnson syndrome, itching, peripheral edema, hypotension
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to protect it from air and moisture, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the efficacy and safety of the medication.
Dark yellow round film-coated tablet
28 tablets (Alu-Alu: 14 tablets x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Samsung Pharma Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.